Logotype for TreeHouse Foods Inc

TreeHouse Foods (THS) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for TreeHouse Foods Inc

Q4 2024 earnings summary

23 Dec, 2025

Executive summary

  • Q4 2024 adjusted net sales reached $911.4 million and adjusted EBITDA was $118.3 million, both in line with expectations, with nearly 4% growth driven by improved volume and mix despite supply chain and recall challenges.

  • Fiscal year 2024 adjusted net sales were $3.38 billion and adjusted EBITDA was $337 million, reflecting stable performance and margin gains amid a difficult consumer environment.

  • The company completed the acquisition of Harris Tea in January 2025, enhancing private label tea capabilities and expected to be accretive to net sales and EBITDA.

  • Voluntary recall of frozen griddle products led to temporary facility closure, with production and shipments resuming in Q1 2025 and minimal expected financial impact.

  • Executed supply chain and margin management initiatives, driving profitability despite macroeconomic headwinds.

Financial highlights

  • Q4 2024 adjusted net sales increased 0.2% year-over-year to $911.4 million; adjusted EBITDA rose 9.1% to $118.3 million, with margin improving to 13%.

  • Fiscal 2024 adjusted net sales were $3.38 billion and adjusted EBITDA was $337 million, both within guidance.

  • Free cash flow for FY 2024 was $126.1 million, up from $16.5 million in 2023.

  • Q4 gross profit margin improved to 19.5% from 16.7% a year ago, driven by supply chain savings and insurance recovery.

  • Q4 operating expenses fell by $13.3 million year-over-year, reflecting lower incentive compensation and reduced severance and freight costs.

Outlook and guidance

  • Fiscal 2025 adjusted net sales are expected between $3.34 billion and $3.4 billion, flat at the midpoint, with volume and mix expected to decline ~1% year-over-year.

  • Adjusted EBITDA for 2025 is expected in the range of $345–$375 million; free cash flow projected at least $130 million.

  • Q1 2025 adjusted net sales are expected at $785–$800 million (down ~3.5% year-over-year), and adjusted EBITDA at $38–$46 million.

  • Capital expenditures for 2025 are projected at $125 million, with a multi-year glide path to lower CapEx rates.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more